BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 31468068)

  • 1. Drug-induced osteoporosis/osteomalacia: analysis in the French and Spanish pharmacovigilance databases.
    Dardonville Q; Salguiero E; Rousseau V; Chebane L; Faillie JL; Gautier S; Montastruc JL; Carvajal A; Bagheri H
    Eur J Clin Pharmacol; 2019 Dec; 75(12):1705-1711. PubMed ID: 31468068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone disease associated with antiepileptic drugs.
    Pack AM; Gidal B; Vazquez B
    Cleve Clin J Med; 2004 Feb; 71 Suppl 2():S42-8. PubMed ID: 15379299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antiepileptic drug-induced osteopathy. Subtypes, pathogenesis, prevention, early diagnosis and treatment].
    Bartl R
    Dtsch Med Wochenschr; 2007 Jul; 132(27):1475-9. PubMed ID: 17583832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drugs and cancer: an analysis of the French Pharmacovigilance Database.
    Durrieu G; Mazau B; Jégu J; Lapeyre-Mestre M; Delord JP; Montastruc JL;
    Therapie; 2013; 68(3):149-54. PubMed ID: 23886459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Drug-induced bone pathology].
    Schiano A; Chouc PY; Desnuelle C; Serratrice G
    Ann Med Interne (Paris); 1989; 140(7):605-8. PubMed ID: 2692491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in spontaneous adverse drug reaction reports to the French pharmacovigilance system (1986-2001).
    Thiessard F; Roux E; Miremont-Salamé G; Fourrier-Réglat A; Haramburu F; Tubert-Bitter P; Bégaud B
    Drug Saf; 2005; 28(8):731-40. PubMed ID: 16048358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Non-corticosteroid drug-induced metabolic bone disease].
    Briot K
    Presse Med; 2006 Oct; 35(10 Pt 2):1579-83. PubMed ID: 17028524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-induced progressive multifocal leukoencephalopathy: a case/noncase study in the French pharmacovigilance database.
    Colin O; Favrelière S; Quillet A; Neau JP; Houeto JL; Lafay-Chebassier C; Pérault-Pochat MC;
    Fundam Clin Pharmacol; 2017 Apr; 31(2):237-244. PubMed ID: 27736027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Drug-induced osteoporosis].
    Briot K
    Rev Prat; 2012 Feb; 62(2):187-92. PubMed ID: 22408857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-steroidal anti-inflammatory drug-related hepatic damage in France and Spain: analysis from national spontaneous reporting systems.
    Lapeyre-Mestre M; de Castro AM; Bareille MP; Del Pozo JG; Requejo AA; Arias LM; Montastruc JL; Carvajal A
    Fundam Clin Pharmacol; 2006 Aug; 20(4):391-5. PubMed ID: 16867024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Drug-induced pancreatitis. A review of French spontaneous reports].
    Chebane L; Bagheri H; Hillaire-Buys D; Géniaux H; Yahioui N; Laroche ML; Cottin J; Spreux A; Mosquet B; Pecriaux C; Bellet F; Lambert A; Montastruc JL
    Rev Med Interne; 2015 Sep; 36(9):573-8. PubMed ID: 26045335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Adverse drug reactions (ADRs) to antimalarial drugs. Analysis of spontaneous report from the French pharmacovigilance database (1996-2000)].
    Angles A; Bagheri H; Montastruc JL; Magnaval JF;
    Presse Med; 2003 Jan; 32(3):106-13. PubMed ID: 12610379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-induced aseptic meningitis: 329 cases from the French pharmacovigilance database analysis.
    Bihan K; Weiss N; Théophile H; Funck-Brentano C; Lebrun-Vignes B
    Br J Clin Pharmacol; 2019 Nov; 85(11):2540-2546. PubMed ID: 31318079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations between osteoporosis and drug exposure: A post-marketing study of the World Health Organization pharmacovigilance database (VigiBase®).
    Batteux B; Bennis Y; Bodeau S; Masmoudi K; Hurtel-Lemaire AS; Kamel S; Gras-Champel V; Liabeuf S
    Bone; 2021 Dec; 153():116137. PubMed ID: 34343739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antacid-induced osteomalacia.
    Boutsen Y; Devogelaer JP; Malghem J; Noel H; Nagant de Deuxchaisnes C
    Clin Rheumatol; 1996 Jan; 15(1):75-80. PubMed ID: 8929782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-induced bone loss.
    Tannirandorn P; Epstein S
    Osteoporos Int; 2000; 11(8):637-59. PubMed ID: 11095167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose corticosteroid exposure and osteoporosis intervention in adults.
    Che M; Ettinger B; Nguyen MT; Pressman AR; Johnston J
    Ann Allergy Asthma Immunol; 2006 Oct; 97(4):497-501. PubMed ID: 17069105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of inhaled corticosteroids on bone.
    Mortimer KJ; Harrison TW; Tattersfield AE
    Ann Allergy Asthma Immunol; 2005 Jan; 94(1):15-21; quiz 22-3, 79. PubMed ID: 15702810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is enough attention being given to the adverse effects of corticosteroid therapy?
    Hougardy DM; Peterson GM; Bleasel MD; Randall CT
    J Clin Pharm Ther; 2000 Jun; 25(3):227-34. PubMed ID: 10886467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of asthma with osteopenia, osteoporosis, osteomalacia, and fractures.
    Shaheen MS; Silverberg JI
    Allergy Asthma Proc; 2020 Mar; 41(2):112-119. PubMed ID: 32122447
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.